Affidea Centrum Leczenia Zaburzeń Pamięci

At Affidea Centrum Leczenia Zaburzeń Pamięci in Warsaw, the clinical trial portfolio focuses on nervous system diseases, with studies centered on Alzheimer’s disease and migraine. The research is aimed at finding better ways to manage symptoms, slow disease progression, and improve everyday functioning for people affected by these conditions.

• Studies in agitation associated with Alzheimer’s disease are evaluating new approaches to ease behavioral symptoms linked to memory loss.
• Research in early symptomatic Alzheimer’s disease is examining whether treatment can help delay clinical decline and support cognitive health.
• Trials in episodic migraine and chronic migraine are testing preventive therapies designed to reduce attack frequency and improve quality of life.

This site’s work brings together neurodegenerative and headache disorder research, reflecting a strong interest in both symptom relief and disease-modifying care.